Technology developed within the Department is protected and licensed through Cambridge Enterprise either to existing companies or new spin-outs.
The following companies have been founded around the research activities of the Department.
Affinity Chromatography Ltd. (now part of Prometic Life Sciences Inc.) was founded in 1987 to commercialise expertise in custom affinity reagents.
Cambridge Sensors Ltd develops high technology sensors for the health care and environmental sectors.
Enval is a company leader in recycling and environmental technologies. The company has developed unique recycling processes that provide financially lucrative and environmentally beneficial alternatives to landfilling. The main areas of expertise is the recycling of laminated packaging waste. Our technology extracts commercially usable aluminium, oil and gas from laminated packaging waste, such as drink cartons (e.g. Tetra Pak), food pouches, and toothpaste tubes, allowing the waste to be completely recycled in an economically viable way. Enval offers a safe, clean, environmentally and economically friendly alternative to the constantly increasing costs of disposing waste via landfill.
H+Energy is developing a solar-based technology that will provide a significant source of exploitable energy. H+Energy aims to develop a device using synthetic solar cell technology combined with photosynthetic organisms: the Bio-Photovoltaic Device (BPV).
Lumora Ltd founded in 2002 has world-leading expertise in applications of bioluminescence, and is exploiting key intellectual property to develop a new generation of common-platform assays for diagnostics and environmental monitoring.
PsyNova. A key component of the Cambridge Centre for Neuropsychiatric Research has been the establishment of a spin-out company, Psynova Neurotech Ltd, to act as a seamless route to commercialise its research. PsyNova Neurotech Ltd provides a vehicle to exchange results, resources and people between the academic Centre and the company by exploiting the results of the work of the Centre, and sustaining the research programme via joint grants and contracts.
Purely Proteins is an informatics-led protein purification company founded in 2002.
Smart Holograms is pioneering a new technology ("sensor holograms") to develop innovative, non-invasive and multi-analyte diagnostics for applications in the development of "Advanced Systems for Disease Diagnosis and Management". These devices are mainly being commercialized in the areas of monitoring metabolic (e.g. diabetes) and infectious (e.g. microbial) diseases and in applications for infection control.